Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines

被引:0
作者
Zhidong Hu
Weimin Jiang
Ling Gu
Dan Qiao
Tsugumine Shu
Douglas B. Lowrie
Shui-Hua Lu
Xiao-Yong Fan
机构
[1] Fudan University,Shanghai Public Health Clinical Center, Key Laboratory of Medical Molecular Virology of MOE/MOH
[2] Fudan University,Departments of Infectious Diseases, Huashan Hospital
[3] Wenzhou Medical University,School of Laboratory Medicine and Life Science
[4] Shanghai Emerging and Re-emerging Institute,TB Center
[5] Shanghai Jiaotong University,Ruijin Hospital (North)
[6] ID Pharma,undefined
来源
Journal of Molecular Medicine | 2019年 / 97卷
关键词
Tuberculosis; Sendai virus; DNA vaccine; Prime-boost; T cell responses;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1685 / 1694
页数:9
相关论文
共 318 条
[1]  
Colditz GA(1994)Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 271 698-702
[2]  
Brewer TF(2015)T cells and adaptive immunity to Mycobacterium tuberculosis in humans Immunol Rev 264 74-87
[3]  
Berkey CS(2017)Polyfunctional CD4(+) T cells as targets for tuberculosis vaccination Front Immunol 8 1262-42
[4]  
Wilson ME(2018)Mechanisms of M. tuberculosis immune evasion as challenges to TB vaccine design Cell Host Microbe 24 34-527
[5]  
Burdick E(2013)The immune response in tuberculosis Annu Rev Immunol 31 475-63
[6]  
Fineberg HV(2015)The balance between protective and pathogenic immune responses in the TB-infected lung Nat Immunol 16 57-44
[7]  
Mosteller F(2018)Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost? Expert Rev Vaccines 17 31-1233
[8]  
Jasenosky LD(2012)Prime-boost approaches to tuberculosis vaccine development Expert Rev Vaccines 11 1221-8
[9]  
Scriba TJ(2016)Viral vectors as vaccine carriers Curr Opin Virol 21 1-416
[10]  
Hanekom WA(2012)Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine Curr Gene Ther 12 410-94